This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes Disturbances

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by Meir Medical Center.
Recruitment status was:  Not yet recruiting
Information provided by:
Meir Medical Center Identifier:
First received: January 21, 2010
Last updated: NA
Last verified: January 2010
History: No changes posted
To assess the incidence of occult hepatitis C virus in hemodialysed patients with mild impairment of liver enzymes

Hemodialysed Patients With Impaired Liver Enzymes

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective

Resource links provided by NLM:

Further study details as provided by Meir Medical Center:

Estimated Enrollment: 30
Study Start Date: February 2010
impaired liver enzymes
normal liver enzymes
hepatitis C antibodies positive

Detailed Description:
occult hepatitis C virus will be checked in monocytes of hemodialyzed patients with permanent mild impairment of liver enzymes This population has no evidence of hepatitis B or C according to standard laboratory tests (HVC antibodies,HCV PCR, hepatitis B antibodies) Hepatitis C virus RNA will be performed in peripheral blood mononuclear cells of hemodialysed patients

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
hemodialysis patients with impaired liver enzymes

Inclusion Criteria:

  • Hemodialysed patients with impaired liver enzymes

Exclusion Criteria:

  • hepatitis B and C positive
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01054664

Contact: Eleonora Plotkin, MD 972 9 7472517

Plotkin Eleonora Not yet recruiting
Kfar Saba, Israel
Contact: Osnat Klein, MD    972 9 7472517   
Sponsors and Collaborators
Meir Medical Center
  More Information

Responsible Party: Plotkin Eleonora, Clalit Health services Identifier: NCT01054664     History of Changes
Other Study ID Numbers: nephrop003
Study First Received: January 21, 2010
Last Updated: January 21, 2010

Keywords provided by Meir Medical Center:
liver enzymes
peripheral mononuclear blood cells
hepatitis C
RNA processed this record on September 21, 2017